# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA4739783 | B | Inhibition of CDK2 (unknown origin) | Homo sapiens | 37 | ALA4739712 | single protein format | Patent Bioactivity Data | |
2. | ALA4739784 | B | Inhibition of CDK7 (unknown origin) | Homo sapiens | 37 | ALA4739712 | single protein format | Patent Bioactivity Data | |
3. | ALA4739785 | B | Inhibition of CDK9 (unknown origin) | Homo sapiens | 37 | ALA4739712 | single protein format | Patent Bioactivity Data | |
4. | ALA4739786 | F | Antiproliferative activity against human HAP1 cells measured after 72 hrs by CellTiter-Glo Luminescent Cell Viability Assay | Homo sapiens | 15 | ALA4739712 | cell-based format | Patent Bioactivity Data | |
5. | ALA4739787 | F | Antiproliferative activity against human HAP1 cells harboring CDK12 C1039S/CDK13 C1017S double mutant measured after 72 hrs by CellTiter-Glo Luminescent Cell Viability Assay | Homo sapiens | 15 | ALA4739712 | cell-based format | Patent Bioactivity Data | |
6. | ALA4739791 | B | Inhibition of biotinylated-THZ1 binding to CDK12/CDK13 in human Jurkat cells assessed as reduction in cyclin K pull down at 500 nM preincubated for 6 hrs followed by biotinylated-THZ1 addition by Western blotting based pulldown assay | Homo sapiens | 13 | ALA4739712 | cell-based format | Patent Bioactivity Data |